Guwahati Mail

Animal Vaccines Market Size Worth $16.27 Billion By 2028 | CAGR: 7.5% : Exclusive Study by Polaris Market Research

 Breaking News
  • No posts were found

Animal Vaccines Market Size Worth $16.27 Billion By 2028 | CAGR: 7.5% : Exclusive Study by Polaris Market Research

November 04
18:48 2021
Animal Vaccines Market Size Worth $16.27 Billion By 2028 | CAGR: 7.5% : Exclusive Study by Polaris Market Research
Polaris Market Research.
The new published report by Polaris Market Research The global animal vaccines market was valued at USD 9.24 billion in 2020 and is expected to reach USD 16.27 billion by 2028 to grow at a CAGR of 7.5% during the forecast period

The global animal vaccines market size is expected to reach USD 16.27 billion by 2028 according to a new study by Polaris Market Research. The report “Animal Vaccines Market Share, Size, Trends, Industry Analysis Report, By Product (Attenuated Live Vaccines, Inactivated, Subunit, DNA, Recombinant); By Animal Type; By Region; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing cases of zoonotic diseases and the rising number of infectious diseases in different types of meat that are slowing the growth of the industry will be the main factors responsible for the development of the global market. The emergence of modern recombinant injections and the investment by governments for mass immunization programs are anticipated to fuel the market growth further.

Request A Sample Report At :

Animal Vaccines Market Size, By Region, 2016 - 2028(USD Billion)

Competitive Insight

Key Companies: Zoetis, Biogénesis Bagó, Boehringer Ingelheim International GmbH, Ceva, Elanco, Indian Immunologicals Ltd., Intas Pharmaceuticals Ltd., Merck & Co., Inc., Neogen Corporation, Ourofino Saúde Animal, Phibro Animal Health Corporation, and Virbac are some of the key players operating in the global market.

Market Insight :

Zoonotic diseases have been shared across the globe in the past few decades, and more than half of the emerging infectious diseases worldwide are originated from pets. Many diseases have been transmitted from pets to humans, such as Swine flu. Hence, it is necessary to vaccinate food and pets to prevent any such disease from spreading in the coming years.

The introduction of new and innovative technologies such as recombinant serums will develop innovative products in the coming years. These inoculations can overcome the limitations of conventional medicines and hence will be widely adopted. For instance, in April 2021, ICAR-CIBA launched a recombinant vaccine CIBA-Nodavac-R against nervous necrosis virus (NNV), which affects marine, brackish water, and freshwater fish that results in 100 % mortality in early juvenile and larval stages.

Numerous developments are taking place in the market with the launch of many medications and acquisitions, funding, and collaborations. Zoetis launched the porcine vaccine CircoMax Myco in May 2021, the only vaccine for the protection against Mycoplasma hyopneumoniae and PCV2. Applied LifeSciences & Systems (ALSS) raised USD 7 million in recent funding in May 2021 to automate poultry vaccination systems


Request for Discount Pricing with Your Specific Research Needs At


Polaris Market research has segmented the animal vaccines market report on the basis of product, animal type, and region


 Animal Vaccines, Product Outlook (Revenue – USD Million, 2016 – 2028)

  • Attenuated live vaccines
  • Inactivated vaccines
  • Subunit vaccines
  • DNA vaccines
  • Recombinant vaccines


Animal Vaccines, Animal Type Outlook (Revenue – USD Million, 2016 – 2028)

  • Poultry
    • Infectious bronchitis
    • Avian influenza
    • Marek’s disease
    • Newcastle disease
    • Salmonella
    • Others
  • Aqua
    • Bacterial
    • Viral
    • Others
  • Ruminants
    • Foot & Mouth Disease (FMD)
    • Lumpy skin
    • Rotavirus
    • Coronavirus
    • Coli
    • Others
  • Companion
    • Canine
      • Distemper
      • Kennel cough
      • Parvovirus
      • Canine herpes
      • Lyme disease
      • Rabies
    • Feline
      • Rhinotracheitis
      • Calicivirus
      • Coronavirus
      • Panleukopenia
      • Rabies
  • Swine
    • Swine influenza
    • Classical Swine Fever (CSF)
    • Porcine Parvovirus (PPV)
    • Porcine Circovirus Type 2 (PCV2)
    • M.Hyo
    • Actinobacillus Pleuropneumoniae
    • PRRS
    • Foot & mouth disease
    • Pseudorabies
    • PEDV (coronavirus)
    • Others


Animal Vaccines, Regional Outlook (Revenue – USD Million, 2016 – 2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Austria
    • Netherlands
  • Asia Pacific
    • China
    • Japan
    • India
    • Indonesia
    • Malaysia
    • South Korea
  • Latin America
    • Brazil
    • Argentina
    • Mexico
  • Middle East & Africa
    • Israel
    • Saudi Arabia
    • South Africa
    • UAE


Have Any Query Or Specific Requirement? Feel Free To Ask Our Industry Experts At:




Other Studies Relevant to this industry:


About Polaris Market Research

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavour to deliver value-added business solutions to our customers

Media Contact
Company Name: Polaris Market Research and Consulting
Contact Person: Likhil
Email: Send Email
Phone: +1-917-985-9017
Address:30 Wall Street 8th Floor, New York City, NY 10005, United States
City: New York City
State: US
Country: United Kingdom